Rhythm Biosciences launches enhanced geneType test
Rhythm Biosciences (ASX:RHY) has launched its updated geneType colorectal cancer risk assessment test, integrating genetic, clinical, and lifestyle factors to improve early identification of individuals at elevated risk of colorectal cancer.











